Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies
Analgesic Effect of Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies: A Randomized Controlled Trial
Tanta University
44 participants
May 23, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the analgesic effect of superior hypogastric plexus block combined with transversus abdominis plane block in abdominal hysterectomies.
Eligibility
Inclusion Criteria3
- Age ≥ 18 years.
- American Society of Anesthesiology (ASA) physical status I-II.
- Undergoing abdominal hysterectomies under general anesthesia (GA).
Exclusion Criteria8
- History of allergies to local anesthetics.
- Body mass index (BMI) >35 kg/m2.
- Opioid dependency.
- Cognitive impairment.
- Bleeding or coagulation disorders.
- Psychiatric and neurological disorder.
- Local infection at the site of injection.
- Severe heart, lung, liver, and renal dysfunction.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive superior hypogastric plexus block (SHPB) using 20ml of bupivacaine 0.25%+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.
Patients will receive superior hypogastric plexus block (SHPB) using 20ml of saline 0.9% (sham)+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07606781